165 related articles for article (PubMed ID: 32045214)
1. Surface Plasmon Resonance-Based Membrane Protein-Targeted Active Ingredients Recognition Strategy: Construction and Implementation in Ligand Screening from Herbal Medicines.
Chen L; Lv D; Wang S; Wang D; Chen X; Liu Y; Hong Z; Zhu Z; Cao Y; Chai Y
Anal Chem; 2020 Mar; 92(5):3972-3980. PubMed ID: 32045214
[TBL] [Abstract][Full Text] [Related]
2. Surface plasmon resonance biosensor combined with lentiviral particle stabilization strategy for rapid and specific screening of P-Glycoprotein ligands.
Cao Y; Cao Y; Shi Y; Cai Y; Chen L; Wang D; Liu Y; Chen X; Zhu Z; Hong Z; Chai Y
Anal Bioanal Chem; 2021 Mar; 413(7):2021-2031. PubMed ID: 33528601
[TBL] [Abstract][Full Text] [Related]
3. Identification of a ligand for tumor necrosis factor receptor from Chinese herbs by combination of surface plasmon resonance biosensor and UPLC-MS.
Cao Y; Li YH; Lv DY; Chen XF; Chen LD; Zhu ZY; Chai YF; Zhang JP
Anal Bioanal Chem; 2016 Jul; 408(19):5359-67. PubMed ID: 27225174
[TBL] [Abstract][Full Text] [Related]
4. Label-free detection of small-molecule binding to a GPCR in the membrane environment.
Heym RG; Hornberger WB; Lakics V; Terstappen GC
Biochim Biophys Acta; 2015 Aug; 1854(8):979-86. PubMed ID: 25882196
[TBL] [Abstract][Full Text] [Related]
5. Identification of eupatilin and ginkgolide B as p38 ligands from medicinal herbs by surface plasmon resonance biosensor-based active ingredients recognition system.
Chen L; Wang D; Lv D; Wang X; Liu Y; Chen X; Zhang H; Zhu Z; Hong Z; Cao Y; Chai Y
J Pharm Biomed Anal; 2019 Jul; 171():35-42. PubMed ID: 30965219
[TBL] [Abstract][Full Text] [Related]
6. Biosensor-Based Active Ingredients Recognition System for Screening STAT3 Ligands from Medical Herbs.
Chen L; Lv D; Chen X; Liu M; Wang D; Liu Y; Hong Z; Zhu Z; Hu X; Cao Y; Yang J; Chai Y
Anal Chem; 2018 Aug; 90(15):8936-8945. PubMed ID: 29953204
[TBL] [Abstract][Full Text] [Related]
7. Real-time detection of the chemokine CXCL12 in urine samples by surface plasmon resonance.
Vega B; Calle A; Sánchez A; Lechuga LM; Ortiz AM; Armelles G; Rodríguez-Frade JM; Mellado M
Talanta; 2013 May; 109():209-15. PubMed ID: 23618162
[TBL] [Abstract][Full Text] [Related]
8. Surface plasmon resonance spectroscopy for characterisation of membrane protein-ligand interactions and its potential for drug discovery.
Patching SG
Biochim Biophys Acta; 2014 Jan; 1838(1 Pt A):43-55. PubMed ID: 23665295
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of a fluorescent derivative of AMD3100 and its interaction with the CXCR4 chemokine receptor.
Knight JC; Hallett AJ; Brancale A; Paisey SJ; Clarkson RW; Edwards PG
Chembiochem; 2011 Nov; 12(17):2692-8. PubMed ID: 21998043
[TBL] [Abstract][Full Text] [Related]
10. Development of a Novel SPR Assay to Study CXCR4-Ligand Interactions.
Boonen A; Singh AK; Hout AV; Das K; Loy TV; Noppen S; Schols D
Biosensors (Basel); 2020 Oct; 10(10):. PubMed ID: 33096938
[TBL] [Abstract][Full Text] [Related]
11. In vitro reconstitution and preparative purification of complexes between the chemokine receptor CXCR4 and its ligands SDF-1alpha, gp120-CD4 and AMD3100.
Dukkipati A; Vaclavikova J; Waghray D; Garcia KC
Protein Expr Purif; 2006 Dec; 50(2):203-14. PubMed ID: 16962791
[TBL] [Abstract][Full Text] [Related]
12. Methods to immobilize GPCR on the surface of SPR sensors.
Martínez-Muñoz L; Barroso R; Paredes AG; Mellado M; Rodríguez-Frade JM
Methods Mol Biol; 2015; 1272():173-88. PubMed ID: 25563184
[TBL] [Abstract][Full Text] [Related]
13. A novel strategy of profiling the mechanism of herbal medicines by combining network pharmacology with plasma concentration determination and affinity constant measurement.
Chen L; Lv D; Wang D; Chen X; Zhu Z; Cao Y; Chai Y
Mol Biosyst; 2016 Oct; 12(11):3347-3356. PubMed ID: 27754507
[TBL] [Abstract][Full Text] [Related]
14. Real-time monitoring of binding events on a thermostabilized human A2A receptor embedded in a lipid bilayer by surface plasmon resonance.
Bocquet N; Kohler J; Hug MN; Kusznir EA; Rufer AC; Dawson RJ; Hennig M; Ruf A; Huber W; Huber S
Biochim Biophys Acta; 2015 May; 1848(5):1224-33. PubMed ID: 25725488
[TBL] [Abstract][Full Text] [Related]
15. Surface plasmon resonance for high-throughput ligand screening of membrane-bound proteins.
Maynard JA; Lindquist NC; Sutherland JN; Lesuffleur A; Warrington AE; Rodriguez M; Oh SH
Biotechnol J; 2009 Nov; 4(11):1542-58. PubMed ID: 19918786
[TBL] [Abstract][Full Text] [Related]
16. Technical advance: Surface plasmon resonance-based analysis of CXCL12 binding using immobilized lentiviral particles.
Vega B; Muñoz LM; Holgado BL; Lucas P; Rodríguez-Frade JM; Calle A; Rodríguez-Fernández JL; Lechuga LM; Rodríguez JF; Gutiérrez-Gallego R; Mellado M
J Leukoc Biol; 2011 Aug; 90(2):399-408. PubMed ID: 21593136
[TBL] [Abstract][Full Text] [Related]
17. [Prediction of quality markers of Angong Niuhuang Pills based on LC-MS and pull-down with SPR chips].
Yuan HJ; Chen XY; Chen PZ; Zhang JR; Zhang RS; Xu W; Xu W; Lin XH; Luo ZY
Zhongguo Zhong Yao Za Zhi; 2024 Apr; 49(7):1848-1864. PubMed ID: 38812197
[TBL] [Abstract][Full Text] [Related]
18. Surface plasmon resonance analysis of seven-transmembrane receptors.
Aristotelous T; Hopkins AL; Navratilova I
Methods Enzymol; 2015; 556():499-525. PubMed ID: 25857797
[TBL] [Abstract][Full Text] [Related]
19. Comparison of cell-based assays for the identification and evaluation of competitive CXCR4 inhibitors.
Van Hout A; D'huys T; Oeyen M; Schols D; Van Loy T
PLoS One; 2017; 12(4):e0176057. PubMed ID: 28410420
[TBL] [Abstract][Full Text] [Related]
20. HuR-targeted nanotherapy in combination with AMD3100 suppresses CXCR4 expression, cell growth, migration and invasion in lung cancer.
Muralidharan R; Panneerselvam J; Chen A; Zhao YD; Munshi A; Ramesh R
Cancer Gene Ther; 2015 Dec; 22(12):581-90. PubMed ID: 26494555
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
